Medical Corporation Jun Dermatology Clinic

Osaka 558-0003

0 studies enrolling now · 1 studies all time

What they study most

Prurigo Nodularis

Studies at this site

• A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) — Running, not enrolling